Treatment Monitoring in Multiple Sclerosis—Efficacy and Safety
N Mahmoudi, MP Wattjes - Neuroimaging Clinics, 2024 - neuroimaging.theclinics.com
Multiple sclerosis (MS) is the most frequent chronic inflammatory disease of the central
nervous system in young adults being associated with long-term disability. 1 MR imaging of …
nervous system in young adults being associated with long-term disability. 1 MR imaging of …
Multiple Sclerosis: Clinical Update and Clinically-Oriented Radiologic Reporting
P Nguyen, T Rempe, R Forghani - Magnetic Resonance Imaging …, 2024 - mri.theclinics.com
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. It
affects 2.8 million people worldwide, with a global incidence of 2.1 per 100,000 …
affects 2.8 million people worldwide, with a global incidence of 2.1 per 100,000 …
Paramagnetic rim lesions predict greater long-term relapse rates and clinical progression over 10 years
Background: Paramagnetic rim lesions (PRLs) have been linked to higher clinical disease
severity and relapse frequency. However, it remains unclear whether PRLs predict future …
severity and relapse frequency. However, it remains unclear whether PRLs predict future …
Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation
D Jakimovski, F Qureshi, M Ramanathan… - Journal of the …, 2024 - Elsevier
Background Atrophied lesion volume (aLV), a proposed biomarker of disability progression
in multiple sclerosis (MS) and transition into progressive MS (PMS), depicts chronic …
in multiple sclerosis (MS) and transition into progressive MS (PMS), depicts chronic …